InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,862.00
(
-1.16%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
87.49
(
0.30%
)
Bitcoin
63,996.32
(
-0.44%
)
Post# of 45792
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Let's Roll

Send PM Follow Ignore
Followers 883
Posts 304355
Boards Moderated 5
Alias Born 06/09/2006

Let's Roll

Re: None

Thursday, 09/22/2016 6:49:50 AM

Thursday, September 22, 2016 6:49:50 AM

Post# of 45792
$RGBP The experiments revealed that administration of Regen's proprietary compounds RG-NA01, RG-NI01 and RG-NI02 prevented cells of the immune system from producing the inflammatory factors interleukin-2, interferon-gamma, tumor necrosis factor-alpha and, importantly, interleukin-17a. These factors are critically involved in the immune response found in autoimmune diseases such as rheumatoid arthritis and psoriasis

http://tinyurl.com/ztyofyj

$RGBPP #biotech #houseofrespect #jobs #pharma #stocktip #job #science #ipo #goog #googl #AMGN #BIIB #CELG #GILD #REGN #VRTX #MYL

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up